Cemiplimab Plus Chemotherapy Versus Chemotherapy Alone in Advanced NSCLC: 2-Year Follow-Up From the Phase 3 EMPOWER-Lung 3 Part 2 Trial

Tamta Makharadze, Miranda Gogishvili, Tamar Melkadze, Ana Baramidze, Davit Giorgadze, Konstantin Penkov, К. К. Лактионов, Gia Nemsadze, Marina Nechaeva, Irina Rozhkova, Ewa Kalinka‐Warzocha, Siyu Li, Yuntong Li, Manika Kaul, Ruben G.W. Quek, Jean‐François Pouliot, Frank Seebach, Israel Lowy, Giuseppe Gullo, Petra Rietschel